Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GETUG 13: Dose-Dense Chemotherapy in Poor-Prognosis NSGCT
NCT00104676Phase 3Completed
- Sponsor
- Unicancer
- Start
- Nov 2003
- Primary completion
- Mar 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of paclitaxel, oxaliplatin, ifosfamide in non-seminomatous germ cell tumor (NSGCT), sponsored by Unicancer. Started Nov 2003; status: completed.
02
Drugs
paclitaxeloxaliplatinifosfamide
03
Conditions
non-seminomatous germ cell tumor (NSGCT)
Beyond the preview
Go deeper on NCT00104676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104676.